- Home
- IVAC vs BNTC Comparison
IVAC vs BNTC Comparison
Compare IVAC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVAC
- BNTC
- Stock Information
- Founded
- IVAC 1990
- BNTC 1995
- Country
- IVAC United States
- BNTC United States
- Employees
- IVAC N/A
- BNTC N/A
- Industry
- IVAC Industrial Machinery/Components
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- IVAC Technology
- BNTC Health Care
- Exchange
- IVAC Nasdaq
- BNTC Nasdaq
- Market Cap
- IVAC 94.7M
- BNTC 88.1M
- IPO Year
- IVAC 1995
- BNTC N/A
- Fundamental
- Price
- IVAC $3.49
- BNTC $10.30
- Analyst Decision
- IVAC Hold
- BNTC Buy
- Analyst Count
- IVAC 1
- BNTC 6
- Target Price
- IVAC N/A
- BNTC $23.83
- AVG Volume (30 Days)
- IVAC 65.3K
- BNTC 82.8K
- Earning Date
- IVAC 02-03-2025
- BNTC 02-11-2025
- Dividend Yield
- IVAC N/A
- BNTC N/A
- EPS Growth
- IVAC N/A
- BNTC N/A
- EPS
- IVAC N/A
- BNTC N/A
- Revenue
- IVAC $65,569,000.00
- BNTC N/A
- Revenue This Year
- IVAC $21.36
- BNTC N/A
- Revenue Next Year
- IVAC N/A
- BNTC N/A
- P/E Ratio
- IVAC N/A
- BNTC N/A
- Revenue Growth
- IVAC 28.52
- BNTC N/A
- 52 Week Low
- IVAC $2.46
- BNTC $2.70
- 52 Week High
- IVAC $4.51
- BNTC $13.29
- Technical
- Relative Strength Index (RSI)
- IVAC 57.86
- BNTC 41.00
- Support Level
- IVAC $3.41
- BNTC $10.20
- Resistance Level
- IVAC $3.55
- BNTC $11.39
- Average True Range (ATR)
- IVAC 0.11
- BNTC 0.87
- MACD
- IVAC -0.01
- BNTC -0.19
- Stochastic Oscillator
- IVAC 50.00
- BNTC 3.58
About IVAC Intevac Inc.
Intevac Inc designs and develops high-productivity, thin-film processing systems. The company's production platforms are designed for high-volume manufacturing of substrates with precise thin-film properties, such as the hard disk drive, display cover panel. The Thin Film Equipment segment also previously designed, developed, and marketed manufacturing equipment for the photovoltaic solar cell and semiconductor packaging industries. Geographically, the majority of revenue is generated from Asia.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.